Loading…

Immediate versus delayed sequential bilateral cataract surgery

[...]when interpreting these results, one should consider that the adjustment of intraocular lens power to the second eye for the DSBCS procedure was based on a 1-week refractive outcome for the first eye and the refraction might not be stable at such an early stage, and whether the refractive outco...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2023-06, Vol.401 (10392), p.1907-1909
Main Authors: Dmuchowska, Diana Anna, Obuchowska, Iwona, Konopinska, Joanna
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]when interpreting these results, one should consider that the adjustment of intraocular lens power to the second eye for the DSBCS procedure was based on a 1-week refractive outcome for the first eye and the refraction might not be stable at such an early stage, and whether the refractive outcome in both groups would still be similar if the study included patients with higher refractive errors. [...]visual recovery after DSBCS takes twice as long as after ISBCS, which causes a delay in the return to professional activities and the activities of daily living. [...]some studies demonstrated that because of postoperative anisometropia and binocular vision disorders, the risk of accidents and traumatic events, such as leg fractures or traffic accidents with the patient as a driver, increases in the period between the surgery for one eye and the other eye.5 As shown by Spekreijse and colleagues,4 even in their cohort selected based on the axial length criterion, patients undergoing DSBCS reported disturbing anisometropia between the first-eye and the second-eye surgery significantly more often. The results of the cost-effectiveness analysis by Spekreijse and colleagues4 refer to a short period and should be interpreted in the specific context of the trial, country, and patient population. [...]future studies would benefit from including different scenarios considering both costs and the clinical outcomes throughout the patient's lifetime.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(23)00692-X